Seegene Launches the First Fully Automated PCR System at ADLM 2025, Aiming to Transform Global Diagnostics

Seegene Unveils CURECA™: A Groundbreaking Step in Diagnostics

Seegene Inc., a global leader in molecular diagnostics, recently made headlines by announcing the launch of its fully automated PCR testing system, CURECA™, at the ADLM 2025 conference. This landmark event, held in Chicago from July 28 to July 31, set the stage for what could be a significant paradigm shift in diagnostic testing and analysis.

The Future of PCR Testing

The CURECA™ system is the first of its kind to completely automate every step in the PCR testing process, encompassing everything from sample preparation to nucleic acid extraction, amplification, and data analysis. With this innovative technology, Seegene aims to minimize human error and enhance the consistency and reliability of test results, ensuring a level of efficiency previously unattainable in laboratories.

At the heart of CURECA™ is its fully automated preparation module, which is designed to carry out one of the most tedious and error-prone tasks in laboratory workflows. Historically, sample preparation has posed challenges, particularly when dealing with diverse biological materials such as urine, blood, and stool. Considering the high viscosity and solid content of stool samples, automating this preparation step has typically been fraught with difficulties. However, CURECA™ successfully navigates these challenges, fully automating the preparation process for all key sample types and thus revolutionizing laboratory operational standards.

Laboratory technicians will no longer need to focus solely on these manual steps. With the implementation of CURECA™, they can now channel their expertise towards more complex tasks, such as data analysis and clinical interpretation. This change promises not only to improve testing efficiency but also to elevate the overall quality of output in high-throughput testing environments.

Introducing STAgora™: Real-Time Data Integration

In addition to CURECA™, Seegene has introduced STAgora™, a statistical platform designed to collect and analyze real-time PCR diagnostic data to support clinical decision-making. STAgora™ aggregates test results uploaded by hospitals worldwide, producing insights on infection trends, positivity rates, and co-infections across various regions. With more than 40 statistical tools tailored specifically for clinical support, this platform empowers healthcare professionals to compare individual test results with extensive epidemiological data, leading to more accurate treatment strategies.

The integration of such robust analytics capabilities marks a notable advancement in the realm of medical diagnostics. By allowing clinicians to assess infection trends at both the patient and regional levels, STAgora™ enhances the accuracy and speed of diagnoses, setting the stage for more timely and tailored treatment plans.

Strategies for Global Collaboration

Building on the momentum from ADLM 2025, Seegene is set to expand access to CURECA™ and STAgora™ through pilot projects and strategic partnerships. Following a successful showcase earlier this year at the ESCMID Global 2025, interest in CURECA™ has been robust, prompting Seegene to establish local subsidiaries in the U.S., including Seegene Technologies and Seegene CURECA.

Daniel Shin, Executive Vice President and Chief of Global Sales and Marketing at Seegene, stated, “CURECA™ and STAgora™ represent more than just a diagnostic system or software. They set a new global standard that will redefine clinical diagnostics worldwide. We will continue to leverage our technological resources to drive innovative developments within the global diagnostics landscape.”

Conclusion

Seegene's initiatives with CURECA™ and STAgora™ signal not just a technological upgrade but a comprehensive transformation in diagnostic practices and patient care. As laboratories worldwide gear up for this new era of automation, the expectations for improved outcomes and more effective healthcare delivery are higher than ever. With Seegene at the forefront, the future of diagnostics looks promising, ensuring that high-quality healthcare is within reach for everyone.

For more details, please visit Seegene's website and follow them on LinkedIn.